Characterization of Cardiovascular Risk Profile and Therapeutic Management in Patients With Type 2 Diabetes Mellitus in Italy - CardioMET Registry
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 3,000
- 试验地点
- 1
- 主要终点
- Diabetes treatment adherence according to the most recent European Guidelines
研究概览
简要总结
CardioMET is an observational, multicenter, real-life registry, intending to collect data on patients with Type 2 Diabetes Mellitus, attending internal medicine and cardiology outpatient clinics. The aim of the registry is to characterize the cardiovascular risk profile and pharmacological management of Type 2 Diabetes Mellitus in Italy, in accordance with current ESC and AHA guidelines for primary and secondary prevention of CV disease.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Other
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age ≥ 18 years;
- •Diagnosis of type 2 diabetes mellitus (T2DM);
- •Ability to understand the study procedures and provide written informed consent.
排除标准
- •Known or suspected liver disease;
- •Patients with type 1 diabetes mellitus;
- •Cardiac surgery or percutaneous coronary revascularization scheduled within the next 3 months;
- •Patients with acute inflammatory or infectious diseases during the previous 3 months;
- •Patients with chronic inflammatory, immune, or infectious diseases;
- •Patients with ongoing malignant neoplasms;
- •History of alcohol, drug, or medication abuse;
- •Clinically significant hematological disorders;
- •Systemic steroid treatment within the last 6 months;
- •Acute-phase metabolic disorders;
- •Any condition that may put the patient at risk by participating in the study.
结局指标
主要结局
Diabetes treatment adherence according to the most recent European Guidelines
时间窗: 12-24-36-48 months
Outpatients clinic treatment adherence will be measured as the percentage of patients receiving guideline-directed medical therapy prescriptions.
次要结局
未报告次要终点
研究者
Pasquale Perrone Filardi
Professor
Federico II University
